Clinical Trials Directory

Trials / Sponsors / Shanghai Ark Biopharmaceutical Co., Ltd.

Shanghai Ark Biopharmaceutical Co., Ltd.

Industry · 18 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AK0406 Injection in Healthy Adult Partici
Healthy Participants
Phase 12026-02-01
Not Yet RecruitingThorough QT/QTc (TQT) Clinical Study to Evaluate the Effects of Ziresovir on Cardiac Repolarization in Healthy
Healthy Volunteers
Phase 12024-09-15
UnknownA Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD
ADHD
Phase 32024-05-01
RecruitingA Clinical Study of AK0610
Healthy Volunteer Study
Phase 12024-02-29
RecruitingA Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants
Respiratory Synctial Virus Infections
Phase 32024-02-29
CompletedA Study of AK0529 in Adults Patients Hospitalized With RSV Infection
Respiratory Syncytial Virus Infections
Phase 22023-07-20
UnknownA Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar
Hypertrophic Scar
Phase 1 / Phase 22022-07-01
UnknownA Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Phase 22022-07-01
CompletedA Study of AK3280 in Chinese Healthy Volunteers
Healthy
Phase 12021-06-09
CompletedA Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Ziresovir in Healthy Subjects
Healthy Subjects
Phase 12021-03-24
CompletedA Study of AK0529 in Chinese Infants Hospitalized With RSV
Respiratory Syncytial Virus Infections
Phase 32020-09-22
CompletedA Study to Assess the Effect of AK3280 on Renal Function in Healthy Subjects
Healthy
Phase 12019-10-03
UnknownAnti-RSV Study in Chinese Patients (ASCENT)
Respiratory Syncytial Virus Infections
Phase 22019-03-29
CompletedA Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of AK0529
Healthy
Phase 12018-01-05
CompletedA Study of AK0529 to Evaluate Pharmacokinetics and Safety in Chinese Healthy Volunteers
Healthy
Phase 12017-10-23
CompletedViral Inhibition in Children for Treatment of RSV
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Phase 22016-05-27
TerminatedA Study of AK0529 in Infants Hospitalized With RSV
Respiratory Syncytial Virus Infections
Phase 12015-08-28
CompletedSafety, Tolerability and PK Study of AK0529 in Healthy Human
Respiratory Syncytial Virus Infections
Phase 12014-10-01